Literature DB >> 21067778

Patient satisfaction and symptomatic outcomes following stapled transanal rectal resection for obstructed defecation syndrome.

Chirag B Patel1, Madhu Ragupathi, Nilesh H Bhoot, T Bartley Pickron, Eric M Haas.   

Abstract

BACKGROUND: Obstructed defecation syndrome (ODS) is recognized as a functional (e.g., anismus) and anatomic (e.g., rectocele and rectal intussusception) defecatory disorder of the pelvic floor. This study was designed to evaluate outcomes and patient satisfaction following stapled transanal rectal resection (STARR) for the surgical treatment of ODS.
MATERIALS AND METHODS: Between May 2006 and July 2009, 37 patients underwent STARR for correction of ODS secondary to rectocele and internal intussusception. Demographic data and postoperative outcomes were tabulated. Symptomatic outcomes were assessed by comparing pre- and postoperative subsets of the Wexner constipation scoring system, and quality outcomes were evaluated with patient satisfaction surveys.
RESULTS: Thirty-seven female patients with a mean age of 52.9 ± 11.2 y underwent STARR. All patients had clinically significant rectocele as evidenced on defecography and 81.1% had concomitant internal rectal intussusception. Postoperative complications occurred in 13 patients (35.1%). Two of these patients required re-intervention: dilation of stricture and transanal excision of staple granuloma. Mean quality of life follow-up occurred at 20.3 ± 6.5 mo (median: 20 mo, range: 9-36 mo). Mean preoperative and postoperative constipation subset scores were 11.1 ± 3.6 and 4.6 ± 3.9, respectively (P < 0.00001). Overall outcome was reported as "excellent" or "good" in 71.9% of patients, "adequate" in 15.6%, and "poor" in 12.5%. When asked if they would undergo the procedure again, 81.3% responded affirmatively.
CONCLUSIONS: The STARR procedure results in improved symptomatic outcomes, high patient satisfaction, and an acceptable complication rate. In selected patients, this minimally invasive approach was an acceptable procedure for the surgical correction of ODS secondary to rectocele and intussusception.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21067778     DOI: 10.1016/j.jss.2010.07.045

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Midterm outcome of stapled transanal rectal resection for obstructed defecation syndrome: a single-institution experience in China.

Authors:  Bin Zhang; Jian-Hua Ding; Yu-Juan Zhao; Meng Zhang; Shu-Hui Yin; Ying-Ying Feng; Ke Zhao
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

Review 2.  [Indications, technique and results of the STARR procedure].

Authors:  O Schwandner; P Hillemanns
Journal:  Chirurg       Date:  2016-11       Impact factor: 0.955

3.  Short-term results after STARR versus internal Delorme for obstructed defecation: a non-randomized prospective study.

Authors:  N L Ohazuruike; J Martellucci; C Menconi; S Panicucci; G Toniolo; G Naldini
Journal:  Updates Surg       Date:  2014-01-16

4.  Prognostic and predictive value of interstitial cells of Cajal populations following stapled transanal rectal resection (STARR) in patients with obstructed defecation syndrome.

Authors:  Hong-Cheng Lin; Hua-Xian Chen; Liang Huang; Ya-Xi Zhu; Qian Zhou; Juan Li; Yu-Jie Xu; Dong-Lin Ren; Jian-Ping Wang
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-10-01

5.  Stapled Transanal Rectal Resection (Starr) in the Treatment of Obstructed Defecation: A Systematic Review.

Authors:  Lorenzo Ripamonti; Angelo Guttadauro; Giulia Lo Bianco; Maria Rennis; Matteo Maternini; Gerardo Cioffi; Marco Chiarelli; Matilde De Simone; Ugo Cioffi; Francesco Gabrielli
Journal:  Front Surg       Date:  2022-02-14

6.  Long-term outcome after resection rectopexy for internal rectal intussusception.

Authors:  Egil Johnson; Kristin Kjellevold; Hans-Olaf Johannessen; Anders Drolsum
Journal:  ISRN Gastroenterol       Date:  2012-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.